platinum has been researched along with Rhabdomyosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brabec, V; Kasparkova, J; Markova, L; Novohradsky, V; Zajac, J | 1 |
| Alimonti, A; Bocca, B; Cappelli, C; Caroli, S; Clerico, A; De Ioris, MA; Petrucci, F; Ragni, G; Sordi, A | 1 |
| Bernard, JL; Breant, V; Bues-Charbit, M; Cano, JP; Gentet, JC; Raybaud, C | 1 |
3 other study(ies) available for platinum and Rhabdomyosarcoma
| Article | Year |
|---|---|
Platinum (IV) Derivatives with Cinnamate Axial Ligands as Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells.
Topics: Cell Differentiation; Cinnamates; Humans; Ligands; Models, Molecular; Neoplastic Stem Cells; Platinum; Rhabdomyosarcoma | 2020 |
Evaluation of carboplatin pharmacokinetics in pediatric oncology by means of inductively coupled plasma mass spectrometry.
Topics: Adolescent; Adult; Antineoplastic Agents; Area Under Curve; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Female; Humans; Male; Mass Spectrometry; Myosarcoma; Neoplasms; Neoplasms, Muscle Tissue; Platinum; Rhabdomyosarcoma | 2006 |
Continuous infusion of high-dose cisplatin in children: pharmacokinetics of free and total platinum.
Topics: Child; Cisplatin; Humans; Infant; Infusions, Parenteral; Neuroblastoma; Platinum; Rhabdomyosarcoma | 1987 |